In 2024, Fujian Province had 344 pharmaceutical enterprises above designated size, generating a total revenue of RMB 60.84 billion. Our province has established a relatively comprehensive pharmaceutical industrial system, covering categories such as chemical APIs (active pharmaceutical ingredients), chemical drug preparations, biopharmaceuticals, traditional Chinese medicine (TCM) preparations, TCM decoction pieces, and medical devices. The biopharmaceutical industry in Fujian Province is primarily concentrated in Xiamen, Sanming, Fuzhou, and Zhangzhou, with these four cities accounting for approximately 80% of our province's total revenue.
Fujian has been committed to innovative development with local features, with a focus on biological drugs, chemical drugs, traditional Chinese medicine, medical devices, and bio-manufacturing industries.
Biological Drugs
Chemical Drugs
Traditional Chinese Medicine
Medical Devices
Bio-manufacturing
Key Investment Promotion Projects
The former Caimao Garment Mall was renovated and upgraded. A bio-pharmaceutical science and technology park with a carrier area of 150,000sqm will be constructed as the carrier for investment promotion in the bio-pharmaceutical and medical instrument industry. Estimated investment of RMB 1 billion.
The project has a total covering area of about 76mu. It is expected to become an industrialization and model base for Internet+ medical service, pharmaceutical and medical device R&D, etc. Estimated investment of RMB 770 million.
Capitalize on the opportunity of the joint development of a regional medical center of traumatic orthopedics with Shanghai No. 6 People's Hospital to attract a series of hi-tech medical device enterprises, develop a high-end medical industrial service platform and develop an industrial cluster of medical equipment R&D, production and sale, primarily including orthopaedic treatment devices. The estimated investment amount depends on project conditions.
Attract production lines of sequoyitol derivative preparation that is an anti-diabetes new drug. Mingxi County has rich Chinese yew resources with a planting area of over 3,000mu now. Estimated investment of RMB 200 million.
Avail the advantageous private medical resources of Putian to plan and construct a medical device and bio-pharmaceutical R&D and production base, headquarters base and warehousing and logistics base. Estimated investment of RMB 3 billion.
Attract and produce medical device enterprises with a high technical intensity, including intelligent recuperation, medical cosmetics, middle and high-end in-vitro diagnostic reagent, high-value medical consumables, etc. Estimated investment of RMB 5 billion.
With a planned covering area of about 250mu, this project primarily produce medical and fitness equipment, including sleep monitor, body temperature monitor, cloud blood pressure gauge, dynamic analytical instrument, low-temperature freezing equipment, dialysis equipment, first-aid device, laser operation instrument, ultrasonic operation and therapeutic device, recuperation machinery, handicapped deviice, etc. Estimated investment of RMB 600 million.
It is expected to avail the cross-strait resources in the greater health sector to develop a greater health model park with a concentration of cross-strait medium and small-size health enterprises. Estimated investment of RMB 1.5 billion.
Investment Carrier
Electronic Information and Digital
Featured Modern Agriculture and Food Processing
New Materials
Biology and New Medicine
Advanced Equipment Manufacturing
Metallurgical
New Energy
Building Materials
Petrochemical
Modern Textiles and Garments
Modern Services
Artificial Intelligence (AI)
Hydrogen Energy and Fuel Cells
New Energy Storage
Low-Altitude Economy